Cynata Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 3 100 Cubitt St, Cremorne, Victoria, 3...Phone Number
+61 370676940Website
www.cynata.comRevenue
<$5 MillionStock Symbol
CYPIndustry
About Cynata Therapeutics
Cynata Therapeutics specializes in regenerative medicine utilizing its proprietary Cymerus Platform, which focuses on the development of therapeutic products derived from mesenchymal stem cells. The company is engaged in clinical and pre-clinical development, offering a pipeline of innovative treatments aimed at addressing various medical conditions. Its intended clients include investors and stakeholders in the biotechnology sector, along with healthcare providers seeking advanced therapeutic solutions. Cynata is committed to advancing its technology and expanding its intellectual property through significant scientific research and publications.Explore more
Cynata Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cynata Therapeutics
Compare insights from companies similar to Cynata Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cynata Therapeutics Tech Stack
A closer look at the technologies used by Cynata Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cynata Therapeutics
Sign Up For FreeTo access detailed company insights
Cynata Therapeutics specializes in regenerative medicine utilizing its proprietary Cymerus Platform, which focuses on the development of therapeutic products derived from mesenchymal stem cells. The company is engaged in clinical and pre-clinical development, offering a pipeline of innovative treatments aimed at addressing various medical condition... Read More
